Vault-13

VOR BIOPHARMA INC VOR

COM NEW · Common Stock · CUSIP 929033207

36 institutional holders +35 vs Q2 2025
3,710,4183.7m shares reported held*
35.6% of all shares outstanding*
$180.8mreported value*
36 new 0 added 0 reduced 1 sold out net bought ≈ $178.1m (+3.7m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 10.4m as of 2025-11-07, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $48.72. Options: 7 managers hold calls ($360.9m notional), 5 hold puts ($57.8m).

Trends to Q3 2025

Institutional holders

Managers reporting a position, each quarter

02040Q1 25: 1Q2 25: 1Q3 25: 3636Q1 25Q2 25Q3 25
Numbers
QuarterHolders
Q1 20251
Q2 20251
Q3 202536

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q2 25: 0 bought or addedQ2 25: 0 cut or sold outQ2 25Q3 25: 36 bought or addedQ3 25: 1 cut or sold outQ3 25
Numbers
QuarterBought or addedCut or sold out
Q2 202500
Q3 2025361

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$100m$200m$300m$400mQ4 24 calls: $0Q4 24 puts: $0Q4 24P/C —Q1 25 calls: $0Q1 25 puts: $0Q1 25P/C —Q2 25 calls: $0Q2 25 puts: $0Q2 25P/C —Q3 25 calls: $360.9mQ3 25 puts: $57.8mQ3 25P/C 0.16
Numbers
QuarterCallsPutsP/C
Q4 2024$0$0—
Q1 2025$0$0—
Q2 2025$0$0—
Q3 2025$360.9m$57.8m0.16

Biggest buyers

RA CAPITAL MANAGEMENT, L.P. New +1,982,301+2.0m
Venrock Adviser, LLC New +499,966+500.0k
FCPM III SERVICES B.V. New +379,640+379.6k
FMR LLC New +236,508+236.5k
Ariose Capital Management Ltd New +110,173+110.2k
VANGUARD GROUP INC New +105,190+105.2k
UBS Group AG New +75,909+75.9k
TANG CAPITAL MANAGEMENT LLC New +50,000+50.0k
BlackRock, Inc. New +34,530+34.5k
GEODE CAPITAL MANAGEMENT, LLC New +27,392+27.4k

Biggest sellers

DGS Capital Management, LLC Sold out -55,300-55.3k

Biggest calls

SUSQUEHANNA INTERNATIONAL GROUP, LLP New $254.8m5.2m shares
GROUP ONE TRADING LLC New $100.5m2.1m shares
Shay Capital LLC New $2.6m53.8k shares
JANE STREET GROUP, LLC New $1.0m21.3k shares
Hudson Bay Capital Management LP New $1.0m21.2k shares
CITADEL ADVISORS LLC New $736.6k15.1k shares
Belvedere Trading LLC New $280.8k115.1k shares

Biggest puts

Shay Capital LLC New $32.4m666.0k shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP New $20.4m418.8k shares
GROUP ONE TRADING LLC New $4.7m96.4k shares
CITADEL ADVISORS LLC New $220.2k4.5k shares
Belvedere Trading LLC New $4.1k1.7k shares

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
RA CAPITAL MANAGEMENT, L.P. 13D · may seek influence no change · filed 2026-07-21
Stated purposeItem 4 of the Statement is hereby amended and supplemented as follows: Effective July 6, 2026, Andrew Levin resigned from the Board of Directors of the Issuer. Full filing
19.9% no change 12.9m≈ $238.2m 2026-07-21
Reprogrammed Interchange LLC 13D · may seek influence filed 2025-10-17
Stated purposeItem 4 of Schedule 13D is hereby amended and supplemented as follows: From October 15, 2025 through October 16, 2025, Reprogrammed Interchange LLC sold the following shares of Vor Biopharma Inc. in open market transactions, resulting in a decrease in the number of shares of Common Stock beneficially owned by the Reporting Persons by more than one percent of the outstanding shares of Common Stock of the Issuer. 1. 71,655 shares on October 15, 2025, at a weighted average per share sale price of $31.9196. 2. 2,021 shares on October 16, 2025, at a weighted average per share sale price of $30.4548. Full filing
17.6% 1.2m≈ $22.2m 2025-10-17
FMR LLC 13G · institution +2.9 pts · filed 2026-08-07 12.0% +2.9 pts 6.5m≈ $119.8m 2026-08-07
TCG Crossover GP II, LLC 13G · passive investor new · filed 2026-04-01 10.5% new 5.7m≈ $104.4m 2026-04-01
ForGrowth III PA B.V. 13D · may seek influence no change · filed 2025-12-23
Stated purposeThe Reporting Persons acquired their shares of Common Stock as an investment in the ordinary course of business. On December 18, 2025, Wouter Joustra, a General Partner at Forbion Capital, was appointed to the Issuer's board of directors. The Reporting Persons, either directly or indirectly through Mr. Joustra, may engage in discussions from time to time with the Issuer's board of directors, the Issuer's management or the Issuer's other stockholders. These discussions may be with respect to (i) acquiring or disposing of the shares or other securities of the Issuer; (ii) maintaining or changing the Issuer's business, operations, governance, management, strategy or capitalization; or (iii) implementing transactions that may relate to or may result in any matter set forth in paragraphs (a) t… Full filing
10.0% no change 10.2m≈ $119.7m 2025-12-23
Venrock Healthcare Capital Partners III, L.P. 13G · passive investor no change · filed 2026-08-14 9.9% no change 5.7m≈ $104.5m 2026-08-14
Verve Capital Ltd 13G · passive investor -3.0 pts · filed 2026-08-13 6.3% -3.0 pts 3.4m≈ $62.8m 2026-08-13
BlackRock, Inc. 13G · institution new · filed 2026-07-30 5.7% new 3.1m≈ $57.1m 2026-07-30

Fell to 5% or below in the last year: Frazier Life Sciences Public Fund, L.P. (4.2%, 2026-08-14), Qiming Venture Partners VIII-HC, L.P. (2.0%, 2026-05-06), GREAT POINT PARTNERS LLC (3.3%, 2026-02-17), Paradigm Biocapital Advisors LP (4.5%, 2026-02-17)

Insider purchases and sales in Q3 2025

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q4 23: 0 buyingQ4 23: 0 sellingQ1 24: 0 buyingQ1 24: 0 sellingQ1 24Q2 24: 0 buyingQ2 24: 1 sellingQ3 24: 0 buyingQ3 24: 0 sellingQ3 24Q4 24: 0 buyingQ4 24: 1 sellingQ1 25: 0 buyingQ1 25: 1 sellingQ1 25Q2 25: 0 buyingQ2 25: 0 sellingQ3 25: 0 buyingQ3 25: 0 sellingQ3 25
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20230—0——
Q1 20240—0——
Q2 20240—1$20.4k$20.4k
Q3 20240—0——
Q4 20240—1$12.9k$12.9k
Q1 20250—1$6.7k$6.7k
Q2 20250—0——
Q3 20250—0——
DateInsiderTradeSharesPrice ValueTheir holding
2025-09-16 Hoffman Reid +1 10% owner Sold 447,278 $1.54 $688.8k447.3k shares -1%
2025-09-15 Hoffman Reid +1 10% owner Sold 400,000 $1.64 $656.0k400.0k shares -1%
2025-09-12 Hoffman Reid +1 10% owner Sold 300,000 $1.75 $525.0k300.0k shares -1%
2025-09-11 Hoffman Reid +1 10% owner Sold 284,805 $1.83 $521.2k284.8k shares -1%
2025-09-10 Hoffman Reid +1 10% owner Sold 350,000 $1.82 $637.0k350.0k shares -1%
2025-09-09 Hoffman Reid +1 10% owner Sold 449,226 $2.00 $898.5k449.2k shares -1%
2025-09-08 Hoffman Reid +1 10% owner Sold 464,421 $1.99 $924.2k464.4k shares -1%
2025-09-05 Hoffman Reid +1 10% owner Sold 400,000 $1.97 $788.0k400.0k shares -1%
2025-09-04 Hoffman Reid +1 10% owner Sold 453,016 $1.93 $874.3k453.0k shares -1%
2025-09-03 Hoffman Reid +1 10% owner Sold 554,612 $2.00 $1.1m554.6k shares -2%
2025-08-28 Hoffman Reid +1 10% owner Sold 806,351 $2.01 $1.6m806.4k shares -2%
2025-08-27 Hoffman Reid +1 10% owner Sold 611,647 $2.01 $1.2m611.6k shares -2%
2025-08-26 Hoffman Reid +1 10% owner Sold 284,190 $2.08 $591.1k284.2k shares -1%
2025-08-25 Hoffman Reid +1 10% owner Sold 387,346 $2.12 $821.2k387.3k shares -1%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q3 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 RA CAPITAL MANAGEMENT, L.P. 1.19% of their portfolio BOSTON, MA 1,982,3012.0m $96.6m $96.6m 1.19% New
2 Venrock Adviser, LLC 1.37% of their portfolio NEW YORK, NY 499,966500.0k $24.4m $24.4m 1.37% New
3 FCPM III SERVICES B.V. 3.70% of their portfolio NAARDEN, P7 379,640379.6k $18.5m $18.5m 3.70% New
4 FMR LLC 0.00% of their portfolio BOSTON, MA 236,508236.5k $11.5m $11.5m 0.00% New
5 Ariose Capital Management Ltd 1.80% of their portfolio CENTRAL, HONG KONG, K3 110,173110.2k $5.4m $5.4m 1.80% New
6 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 105,190105.2k $5.1m $5.1m 0.00% New
7 UBS Group AG 0.00% of their portfolio ZURICH, V8 75,90975.9k $3.7m $3.7m 0.00% New
8 TANG CAPITAL MANAGEMENT LLC 0.09% of their portfolio SAN DIEGO, CA 50,00050.0k $2.4m $2.4m 0.09% New
9 BlackRock, Inc. 0.00% of their portfolio New York, NY 34,53034.5k $1.7m $1.7m 0.00% New
10 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 27,39227.4k $1.3m $1.3m 0.00% New
11 Woodline Partners LP 0.01% of their portfolio San Francisco, CA 27,36327.4k $1.3m $1.3m 0.01% New
12 Sarissa Capital Management LP 0.69% of their portfolio GREENWICH, CT 25,39925.4k $1.2m $1.2m 0.69% New
13 MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio NEW YORK, NY 24,76424.8k $1.2m $1.2m 0.00% New
14 Polymer Capital Management (HK) LTD 0.14% of their portfolio HONG KONG, K3 21,24821.2k $1.0m $1.0m 0.14% New
15 JANE STREET GROUP, LLC 0.00% of their portfolio NEW YORK, NY 16,75316.8k $816.2k $816.2k 0.00% New
16 GOLDMAN SACHS GROUP INC 0.00% of their portfolio NEW YORK, NY 15,78615.8k $769.1k $769.1k 0.00% New
17 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 14,60014.6k $711.3k $711.3k 0.00% New
18 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 9,0549.1k $441.1k $441.1k 0.00% New
19 Virtu Financial LLC 0.02% of their portfolio New York, NY 8,1048.1k $395.0k $395.0k 0.02% New
20 BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio HOUSTON, TX 6,2506.2k $304.5k $304.5k 0.01% New
21 Scientech Research LLC 0.10% of their portfolio JERSEY CITY, NJ 6,0976.1k $297.0k $297.0k 0.10% New
22 BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio PARIS, I0 6,0756.1k $296.0k $296.0k 0.00% New
23 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 5,6865.7k $277.0k $277.0k 0.00% New
24 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 4,7544.8k $231.6k $231.6k 0.00% New
25 Squarepoint Ops LLC 0.00% of their portfolio NEW YORK, NY 4,7294.7k $230.4k $230.4k 0.00% New
26 Trustees of Columbia University in the City of New York 0.03% of their portfolio NEW YORK, NY 4,5954.6k $223.9k $223.9k 0.03% New
27 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 4,4564.5k $217.1k $217.1k 0.00% New
28 Bollard Group LLC 0.00% of their portfolio BOSTON, MA 2,7772.8k $135.0k $135.0k 0.00% New
29 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 156156 $7.6k $7.6k 0.00% New
30 Caitong International Asset Management Co., Ltd 0.00% of their portfolio HONG KONG, K3 110110 $5.4k $5.4k 0.00% New
31 MAI Capital Management 0.00% of their portfolio INDEPENDENCE, OH 4040 $1.9k $1.9k 0.00% New
32 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 44 $195 $195 0.00% New
33 Allworth Financial LP 0.00% of their portfolio FOLSOM, CA 33 $147 $147 0.00% New
34 SBI Securities Co., Ltd. 0.00% of their portfolio TOKYO, M0 33 $146 $146 0.00% New
35 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 22 $0 $0 0.00% New
36 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 11 $49 $49 0.00% New